We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Clinical Center of Serbia Treats First Patient in Trial of Stem Cell-Derived Therapy for Heart Failure

News   Oct 29, 2009

 
Clinical Center of Serbia Treats First Patient in Trial of Stem Cell-Derived Therapy for Heart Failure
 
 
 

RELATED ARTICLES

Evidence Reinforcing Approval of New Cancer Drugs Raises Questions

News

Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, according to a new study.

READ MORE

Discussing the Pros and Cons of CRISPR

News

CRISPR technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros and cons in a review article in the journal Trends in Cell Biology.

READ MORE

Phase 1 Trial Shows Cell Therapy Could Be a Feasible Treatment for Stroke Patients

News

Researchers have reported that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE